Maximilian Diehn

Stanford University — United States

Medicine · Health Sciences

88h-index55.3kcitations735works9.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(205), Cancer Genomics and Diagnostics(203), Lung Cancer Diagnosis and Treatment(154), Radiomics and Machine Learning in Medical Imaging(81), Lymphoma Diagnosis and Treatment(79)

Publications735 total

AI-enabled virtual spatial proteomics from histopathology for interpretable biomarker discovery in lung cancer
Nature Medicine·2026· 2 citedOpen Access
Supplementary Tables S1-S15 from Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors
2025Open Access
Supplementary Methods & Figures S1-S5 from Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors
2025Open Access
Supplemental Tables from <i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells
2025Open Access
Supplemental Figure 1 from <i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells
2025Open Access
Supplemental Figure 5 from <i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells
2025Open Access
Supplemental Figure 2 from <i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells
2025Open Access
Supplemental Figure 6 from <i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells
2025Open Access
Supplemental Figure 4 from <i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells
2025Open Access
Supplemental Figure 7 from <i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells
2025Open Access
Supplemental Figure 3 from <i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells
2025Open Access
Spatial anatomical genomic heterogeneity and aberrant somatic hypermutation define clonal evolution pathways that predict treatment resistance in aggressive B-cell lymphomas
Blood·2025Open Access
Non-invasive classification & molecular subtyping of mature lymphoid neoplasms by cell-free DNA profiling
Blood·2025Open Access
Non-invasive Mantle Cell Lymphoma risk stratification by inference of tumor proliferation from cfDNA
Blood·2025Open Access
Distinct genomic landscape & response dynamics of HIV-associated lymphomas identified by integrated noninvasive host and virome profiling
Blood·2025Open Access
Tracing malignant precursor mutations and their cellular origins in blood and bone marrow of primary central nervous system lymphomas by ultrasensitive genomic profiling
Blood·2025Open Access
A unified spatial & molecular atlas of anatomically restricted large B-cell lymphomas defines stereotyped cell ecosytems
Blood·2025Open Access
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias
2025Open Access
Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases
Journal of Thoracic Oncology·2025
Association Between Inter-Fraction Volume Changes and Patient Outcomes from Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
Clinical Lung Cancer·2025
page 1 of 37Next →

Frequent Co-authors

Ash A. Alizadeh(32), Chih Long Liu(21), Aaron M. Newman(18), Jacob J. Chabon(15), Mohammad Shahrokh Esfahani(14), David M. Kurtz(14), Henning Stehr(13), Florian Scherer(10), Heather A. Wakelee(9), Joel W. Neal(8), Patrick O. Brown(8), Everett J. Moding(7), Barzin Y. Nabet(7), Andrew J. Gentles(6), Billy W. Loo(6), Alexander F. Lovejoy(6), Emily G. Hamilton(6), Aadel A. Chaudhuri(6), Michael C. Jin(6), David Botstein(6)